Tickers

1. Composite Trajectory Verdict

For a rate-regulated natural gas utility, the income statement matters most because earnings directly reflect the allowed return on rate base and the timeliness of cost recovery through regulatory mechanisms, which drive both shareholder returns and the capacity to fund the capital program.

Composite Trajectory: Improving

Earnings have risen in each of the last three fiscal years (FY2023 $885.9M → FY2024 $1,042.9M → FY2025 $1,198.8M) and the first nine months of FY2026 ($1,227.6M vs $1,023.9M in the prior-year period) (10-K 2025-09-30, Consolidated Statements of Comprehensive Income; 10-Q 2026-06-30, MD&A Executive Summary). Operating cash flow recovered in FY2025 to $2,049.5M from $1,733.7M in FY2024, though it remains well below the FY2023 level that was inflated by a $2.0B Winter Storm Uri regulatory asset collection (10-K 2025-09-30, Consolidated Statements of Cash Flows). The balance sheet shows rising leverage (equity capitalization 61.0% → 60.3% → 59.8% at June 30, 2026) but remains within covenant limits with ample liquidity (~$4.6–4.9B) (10-K 2025-09-30, MD&A Liquidity; 10-Q 2026-06-30, MD&A Executive Summary). The improving earnings and rate-base growth outweigh the moderating equity ratio and persistently negative free cash flow.

2. Red Flags

• Persistently negative and widening free cash flow: Operating cash flow less capital expenditures was -$1.21B in FY2024 and -$1.51B in FY2025, requiring continuous external financing (10-K 2025-09-30, Consolidated Statements of Cash Flows).
• Declining equity capitalization ratio: Fell from 61.0% (Sep 2024) to 60.3% (Sep 2025) to 59.8% (Jun 2026) as debt issuance outpaces equity growth (10-K 2025-09-30, MD&A Liquidity; 10-Q 2026-06-30, MD&A Executive Summary).
• Large regulatory asset/liability balances: $608.7M in regulatory assets and $1,269.6M in regulatory liabilities at Sep 2025 indicate significant timing risk around cost recovery and refund obligations (10-K 2025-09-30, Note 3 Regulation).
• Rising bad debt expense: Increased $17.8M in FY2025 due to a Mississippi regulatory change that had artificially suppressed expense in FY2024 (10-K 2025-09-30, MD&A Distribution Segment).
• Concentration of capex recovery risk: Over 85% of $3.6B FY2025 capex and $3.1B 9M FY2026 capex is for safety/reliability, with full recovery "not assured" per the filing (10-K 2025-09-30, Overview; 10-Q 2026-06-30, Overview).
• Moody's downgrade: Long-term rating downgraded to A2 from A1 in April 2025, though outlook stable (10-K 2025-09-30, Credit Ratings).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Net income has increased in each of the last three fiscal years: $885.9M (FY2023) → $1,042.9M (FY2024) → $1,198.8M (FY2025), a 35% cumulative rise (10-K 2025-09-30, Consolidated Statements of Comprehensive Income). Diluted EPS grew from $6.10 to $6.83 to $7.46 over the same period (10-K 2025-09-30, Consolidated Statements of Comprehensive Income). Operating income rose from $1,067.1M to $1,355.4M to $1,560.0M (10-K 2025-09-30, Consolidated Statements of Comprehensive Income). The nine-month FY2026 net income of $1,227.6M already exceeds the full-year FY2024 total, up 20% year-over-year (10-Q 2026-06-30, MD&A Executive Summary). Both segments contribute: Distribution net income grew from $580.4M to $671.4M to $746.8M; Pipeline and Storage from $305.5M to $371.5M to $452.0M (10-K 2025-09-30, MD&A Results of Operations). Rate outcomes ($333.6M annual operating income increase implemented in FY2025) and customer growth are the primary stated drivers (10-K 2025-09-30, MD&A Overview).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Operating cash flow improved year-over-year to $2,049.5M in FY2025 from $1,733.7M in FY2024, but remains 41% below the FY2023 level of $3,459.7M, which was boosted by a $2.0B collection of Winter Storm Uri regulatory assets (10-K 2025-09-30, Consolidated Statements of Cash Flows). Capital expenditures have risen steadily: $2.81B (FY2023) → $2.94B (FY2024) → $3.56B (FY2025), with 9M FY2026 already at $3.08B (10-K 2025-09-30, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, MD&A Executive Summary). Free cash flow (operating minus capex) has deteriorated from +$654M in FY2023 to -$1.21B in FY2024 to -$1.51B in FY2025. Financing cash flows have consistently funded the gap: $1.48B (FY2024) and $1.41B (FY2025) from debt and equity issuance, plus $2.2B in 9M FY2026 (10-K 2025-09-30, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, MD&A Executive Summary). Dividends paid increased to $553.8M in FY2025 from $493.0M in FY2024 (10-K 2025-09-30, Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Stable

Total assets grew from $25.2B (Sep 2024) to $28.2B (Sep 2025), driven by net PP&E increasing from $22.2B to $25.3B (10-K 2025-09-30, Consolidated Balance Sheets). Long-term debt rose from $7.78B to $8.91B, while shareholders' equity increased from $12.16B to $13.56B (10-K 2025-09-30, Consolidated Balance Sheets). The debt-to-capitalization ratio per covenant definition was 41% at Sep 2025, well below the 70% limit (10-K 2025-09-30, Note 8 Debt Covenants). Equity capitalization declined modestly from 61.0% to 60.3% to 59.8% (Jun 2026) (10-K 2025-09-30, MD&A Liquidity; 10-Q 2026-06-30, MD&A Executive Summary). Liquidity remained robust at ~$4.9B (Sep 2025) and ~$4.6B (Jun 2026), comprising cash, equity forward proceeds, and undrawn credit facilities (10-K 2025-09-30, MD&A Liquidity; 10-Q 2026-06-30, MD&A Executive Summary). Credit ratings stayed investment grade (S&P A-, Moody's A2) with stable outlooks (10-K 2025-09-30, Credit Ratings). Regulatory assets ($608.7M) and liabilities ($1,269.6M) grew modestly (10-K 2025-09-30, Note 3 Regulation).

6. Data Gaps

• Quarterly cash flow statements for any FY2026 quarter (only nine-month capex and financing totals disclosed in 10-Q 2026-06-30 MD&A)
• Full FY2026 annual results (only nine months available)
• Stand-alone Q1, Q2, and Q4 FY2026 income statements (10-Qs for 2025-12-31, 2026-03-31, and 2026-09-30 not provided in full)
• Segment-level quarterly revenue and expense detail beyond the distribution segment tables in 10-Q 2026-06-30
• Quarterly balance sheets for FY2026 (only equity capitalization and liquidity snapshots at Jun 2026)
• Free cash flow for 9M FY2026 (operating cash flow not disclosed for the period)